“Dotz intends to make a secondary CE submission for the Dotz Test Kit in respect of saliva samples, which is expected to occur by 15 March 2021.”
CE approval of the Dotz Saliva-based tests will be a BIG deal - it will not only save us from the unpleasant experience of NP swab sampling , but more importantly will allow a self-sampling. The fact that you need a trained personal to do the sampling today is one of the bottlenecks (and the extra costs) of current diagnostic networks .
“Dotz intends to make a secondary CE submission for the Dotz...
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DTZ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
14.5¢ |
Change
0.015(11.5%) |
Mkt cap ! $75.94M | |||
| Open | High | Low | Value | Volume |
| 14.0¢ | 15.0¢ | 14.0¢ | $33.40K | 231.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 75000 | 14.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 14.5¢ | 6326 | 2 |
View Market Depth
| Last trade - 16.10pm 24/06/2024 (20 minute delay) ? |
| DTZ (ASX) Chart |